Dialog Box

Latest news
See all news
27 Nov 2018 at 12:00AM

Australasian Gastro-Intestinal Trials Group (AGITG) ASM

AGITG Annual Scientific Meeting – Brisbane Convention Centre  31 Oct- 2 Nov 2018

(Written by Meredith Cummins)

The AGITG ASM was well attended by over 300 Health Professionals from Australia and New Zealand. As per previous years this is truly a multidisciplinary meeting which provides updates on current research and trials for gastrointestinal cancers and provides a wonderful opportunity to network with national and international leaders in this field.

Unicorn Foundation CEO Simone Leyden presented data from the INCA/Novartis global survey alongside our recent PET reimbursement survey and Financial Toxicity survey. Please note that the Financial Toxicity survey is still open and we would love to receive more responses to gain greater insight into this area (see below for Simone's slide presentation)

The Unicorn Foundation (UF) had a booth which enabled health professionals to gain access to information and dietary booklets and meet with UF staff to discuss projects currently in progress and future directions in education and collaboration. Many clinicians also signed up for the Healthcare Professionals eNewsletters as the awareness of Neuroendocrine Tumours (NETs) increases.

The Unicorn Foundation submitted a poster for the PLANET Registry which gained much interest from the attendees at the meeting. Within the program were updates on the Unicorn Foundation funded clinical trial CONTROL NETs (Capecitabine, Temozolomide & PRRT vs Capecitabine & Temozolomide vs PRRT) which has reached its recruitment target, NABNEC (A Randomised Phase II Study Of Nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas) which is also studying tumour cells in detail to understand more about the biology of the tumour cells, why tumours can have such different outcomes in different patients and why some tumours become resistant to drugs. NABNEC is currently recruiting till the latter part of 2019. Simone Leyden presented in the Joint Consumer / Study Coordinators forum on the afternoon of 1 November. The topic presented was “Financial Toxicity” which is surveying NET consumers nationally. The Principal Investigator for this survey is Dr David Wyld and it is being coordinated by the University of Brisbane and the Unicorn Foundation nationally. Recruitment for this survey will be completed by the end of November.

There are increasing areas of Research and Clinical Trials being conducted, of which the Unicorn Foundation is very active in providing valuable funding to enable this to improve the care and the outcomes for NET patients.


Category: Advocacy